This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone quarter to September 2026: revenue down 8.8% vs year ago; loss after tax Rs 29.45 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 3.2 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue from operations for the quarter ended 30 September 2026 was Rs 863.97 lakh versus Rs 946.82 lakh a year earlier, down 8.8%. Profit after tax was a loss of Rs 29.45 lakh versus a profit of Rs 14.96 lakh. EBITDA margin fell to 0.25% from 3.12%. Standalone half-year operating cash flow was positive at Rs 69.10 lakh. Borrowings were Rs 1,062.64 lakh against negative equity of Rs 340.26 lakh.
Revenue and profit weakness raises earnings concerns. Negative equity and high borrowings add risk, despite positive half-year operating cash flow.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹8.64 Cr | ₹9.47 Cr | −8.8% |
| Operating profit | −₹0.45 Cr | −₹0.21 Cr | loss widened |
| Profit after tax | −₹0.29 Cr | ₹0.15 Cr | −296.9% |
| EBITDA margin | 0.3% | 3.1% | −2.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.